Ion Beam Applications (Ion Beam Applications) Gross Margin % : 34.48% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Ion Beam Applications Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Ion Beam Applications's Gross Profit for the six months ended in Dec. 2023 was $97.5 Mil. Ion Beam Applications's Revenue for the six months ended in Dec. 2023 was $282.8 Mil. Therefore, Ion Beam Applications's Gross Margin % for the quarter that ended in Dec. 2023 was 34.48%.

Warning Sign:

Ion Beam Applications SA gross margin has been in long-term decline. The average rate of decline per year is -2.3%.

The historical rank and industry rank for Ion Beam Applications's Gross Margin % or its related term are showing as below:

IOBCF' s Gross Margin % Range Over the Past 10 Years
Min: 28.49 Med: 35.84 Max: 43.61
Current: 31.36

During the past 13 years, the highest Gross Margin % of Ion Beam Applications was 43.61%. The lowest was 28.49%. And the median was 35.84%.

IOBCF's Gross Margin % is ranked worse than
78.87% of 795 companies
in the Medical Devices & Instruments industry
Industry Median: 53.37 vs IOBCF: 31.36

Ion Beam Applications had a gross margin of 34.48% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Ion Beam Applications was -2.30% per year.

Ion Beam Applications Gross Margin % Historical Data

The historical data trend for Ion Beam Applications's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ion Beam Applications Gross Margin % Chart

Ion Beam Applications Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

Get a 7-Day Free Trial

32.96

43.61

34.41

35.09

31.36

Ion Beam Applications Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross Margin %	Get a 7-Day Free Trial															35.62	39.10	31.90	26.58	34.48

Competitive Comparison of Ion Beam Applications's Gross Margin %

For the Medical Devices subindustry, Ion Beam Applications's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ion Beam Applications's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Ion Beam Applications's Gross Margin % falls into.

Ion Beam Applications Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Ion Beam Applications's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	146.6	/	467.521
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(467.521 - 320.911)	/	467.521
	=	31.36 %

Ion Beam Applications's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	97.5	/	282.769
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(282.769 - 185.274)	/	282.769
	=	34.48 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Ion Beam Applications (OTCPK:IOBCF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Ion Beam Applications had a gross margin of 34.48% for the quarter that ended in Dec. 2023 => Competition eroding margins

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Ion Beam Applications Gross Margin % Related Terms

Thank you for viewing the detailed overview of Ion Beam Applications's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ion Beam Applications (Ion Beam Applications) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ion Beam Applications SA (OTCPK:IOBCF) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

0GZK:UK IOB:Germany IBAB:Belgium

Address

Chemin du Cyclotron, 3, Louvain-La-Neuve, BEL, B-1348

Website

https://www.iba-worldwide.com

Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in two segments: proton therapy and other accelerators and dosimetry. Proton therapy and other accelerators business contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, and the Rest of the World, with REst-of-World sales generating the largest proportion of revenue.